Actively Recruiting
Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
Led by First Hospital of China Medical University · Updated on 2024-02-28
600
Participants Needed
5
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This multicenter clinical study aims to build an intelligent and accurate diagnosis and dynamic prediction and early warning model of cardiotoxicity due to anthracycline-based breast cancer chemotherapy, clarify the value of the early warning model in guiding the targeted prevention of myocardial protection, providing an important theoretical basis for reducing the mortality rate of breast cancer and improving the prognosis.
CONDITIONS
Official Title
Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Histologically or cytopathological confirmed stage I-III HER2-positive breast cancer
- Scheduled to receive consecutive anthracycline chemotherapy or sequential trastuzumab targeted therapy
- Left ventricular ejection fraction 53% or higher before chemotherapy
You will not qualify if you...
- Life expectancy 12 months or less
- Participation in other ongoing oncology clinical trials
- Prior treatment with anthracyclines or chest radiation therapy
- Pregnant or lactating women
- Very poor quality ultrasound images of the heart
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Fujian Cancer Hospital
Fuzhou, Fujian, China
Actively Recruiting
2
Dalian Friendship Hospital
Dalian, Liaoning, China
Actively Recruiting
3
Dalian Municipal Central Hospital
Dalian, Liaoning, China
Actively Recruiting
4
Liaoning Cancer Hospital & Institute
Shenyang, Liaoning, China
Actively Recruiting
5
The Third People's Hospital Of Chengdu
Chengdu, Sichuan, China
Actively Recruiting
Research Team
Y
Yonghuai Wang, Ph.D
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here